Nasdaq Stockholm AB: Delisting of Karessa Pharma Holding AB (publ) from Nasdaq First North Growth Market (57/20)

Karessa Pharma Holding AB (publ) has applied for its shares to be delisted from
Nasdaq First North Growth Market. 

Conditional upon the Swedish Companies Registration Office's authorization to
implement the merger plan between Karessa Pharma Holding AB (publ) and Klaria
Pharma Holding AB (publ), Nasdaq Stockholm AB has approved the application and
decided to delist the shares in Karessa Pharma Holding AB (publ). 

Short name:     KARE        
----------------------------
ISIN code:      SE0005506193
----------------------------
Order book ID:  106031      
----------------------------


Provided that authorization to implement the merger plan has been given, the
last day of trading will be March 2, 2020. 


For further information concerning this exchange notice please contact Issuer
Surveillance, telephone [phone], or [e-mail]. 



Nasdaq Stockholm AB